Search results
Bernie Sanders to grill Novo Nordisk CEO on why weight-loss drugs Ozempic and Wegovy can cost up to...
INSIDER via Yahoo News· 14 hours agoNovo Nordisk issued a response to Sanders in May, claiming it retained around 60% of the list price...
Bernie Sanders Wants to Subpoena Novo Nordisk Over Wegovy’s Price. What to Know.
Barrons.com· 4 days agosemaglutide, the active ingredient in Wegovy and Ozempic, to be selected for price negotiation...
BofA lifts Novo Nordisk price target on EPS upside potential, upcoming pipeline data By...
Investing.com· 3 days agoBank of America lifted its target price on Novo Nordisk’s (NVO) Denmark-listed shares to DKK 1,150...
Sanders calls vote to subpoena Novo Nordisk president
Becker’s Hospital Review· 6 days agoFollowing jousts between Vermont Sen. Bernie Sanders and Novo Nordisk, the Senate Committee on Health, Education, Labor, and Pensions will vote June 18 ...
Sanders drops subpoena effort after Novo Nordisk CEO agrees to testify
The Hill· 2 days agoSanders announced earlier this week that he would hold a vote to subpoena Doug Langa, the executive...
Structure Therapeutics Stock Could Rocket 87% Higher, According to 1 Wall Street Analyst. Is It Time...
Motley Fool via Yahoo Finance· 6 days agoConsider when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our...
Got $200? 2 Healthcare Stocks to Buy and Hold Forever.
The Motley Fool via AOL· 3 days agoThat's not a bad price to invest in a reliable dividend payer that should deliver steady returns for a long time. Should you invest $1,000 in Novo
Making the case for Wegovy coverage: Drug keeps weight off for 4 years, aids heart health
BenefitsPRO· 5 days agoDrugmaker Novo Nordisk has released two new trial results that could strengthen the case for...
Structure Therapeutics (GPCR) Rallying on Obesity Drug Data
Zacks via Yahoo Finance· 5 days agoStructure Therapeutics (GPCR) stock sees an upside on positive top-line data from a phase IIa...
Why Home-Builder Stocks Can Continue Their Bull Run
Barrons.com· 2 days agoHome inventory is up, but still very low and prices remain high. That means builder profits should remain fat. Plus, exploiting the rush to obesity...